Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy
- Resource Type
- Article
- Source
- In
Immunobiology November 2023 228(6) - Subject
- Language
- ISSN
- 0171-2985